233 related articles for article (PubMed ID: 28844765)
1. Extremely Low Transfusion Rates: Contemporary Primary Total Hip and Knee Arthroplasties.
Lindman IS; Carlsson LV
J Arthroplasty; 2018 Jan; 33(1):51-54. PubMed ID: 28844765
[TBL] [Abstract][Full Text] [Related]
2. Recent Trends in Blood Utilization After Primary Hip and Knee Arthroplasty.
Bedard NA; Pugely AJ; Lux NR; Liu SS; Gao Y; Callaghan JJ
J Arthroplasty; 2017 Mar; 32(3):724-727. PubMed ID: 27866952
[TBL] [Abstract][Full Text] [Related]
3. Recent Trends in Blood Utilization After Revision Hip and Knee Arthroplasty.
Burnett RA; Bedard NA; DeMik DE; Gao Y; Liu SS; Callaghan JJ
J Arthroplasty; 2017 Dec; 32(12):3693-3697. PubMed ID: 28951054
[TBL] [Abstract][Full Text] [Related]
4. National trends in the utilization of blood transfusions in total hip and knee arthroplasty.
Yoshihara H; Yoneoka D
J Arthroplasty; 2014 Oct; 29(10):1932-7. PubMed ID: 24890994
[TBL] [Abstract][Full Text] [Related]
5. Minimizing Blood Transfusion in Total Hip and Knee Arthroplasty Through a Multimodal Approach.
Holt JB; Miller BJ; Callaghan JJ; Clark CR; Willenborg MD; Noiseux NO
J Arthroplasty; 2016 Feb; 31(2):378-82. PubMed ID: 26391927
[TBL] [Abstract][Full Text] [Related]
6. Effect of Body Mass Index on Blood Transfusion in Total Hip and Knee Arthroplasty.
Frisch N; Wessell NM; Charters M; Peterson E; Cann B; Greenstein A; Silverton CD
Orthopedics; 2016 Sep; 39(5):e844-9. PubMed ID: 27172370
[TBL] [Abstract][Full Text] [Related]
7. Are Routine Blood Salvage/Preservation Measures Justified in All Patients Undergoing Primary TKA and THA?
Benjamin JB; Colgan KM
J Arthroplasty; 2015 Jun; 30(6):955-8. PubMed ID: 25662674
[TBL] [Abstract][Full Text] [Related]
8. Role of preoperative anemia for risk of transfusion and postoperative morbidity in fast-track hip and knee arthroplasty.
Jans Ø; Jørgensen C; Kehlet H; Johansson PI;
Transfusion; 2014 Mar; 54(3):717-26. PubMed ID: 23829298
[TBL] [Abstract][Full Text] [Related]
9. Process Improvement Project Using Tranexamic Acid Is Cost-Effective in Reducing Blood Loss and Transfusions After Total Hip and Total Knee Arthroplasty.
Demos HA; Lin ZX; Barfield WR; Wilson SH; Robertson DC; Pellegrini VD
J Arthroplasty; 2017 Aug; 32(8):2375-2380. PubMed ID: 28343823
[TBL] [Abstract][Full Text] [Related]
10. Quality Initiative Programs Can Decrease Total Joint Arthroplasty Transfusion Rates-A Multicenter Study Using the MARCQI Total Joint Registry Database.
Markel DC; Allen MW; Hughes RE; Singal BM; Hallstrom BR
J Arthroplasty; 2017 Nov; 32(11):3292-3297. PubMed ID: 28697866
[TBL] [Abstract][Full Text] [Related]
11. Are Preoperative Serologic Type and Screen Tests Necessary for Primary Total Joint Arthroplasty Patients in Specialty Surgical Hospitals?
Tischler EH; Chen AF; Matthews CN; Arnold WV; Smith EB
J Arthroplasty; 2016 Nov; 31(11):2442-2446. PubMed ID: 27237967
[TBL] [Abstract][Full Text] [Related]
12. Epsilon Aminocaproic Acid to Reduce Blood Loss and Transfusion After Total Hip and Total Knee Arthroplasty.
Hobbs JC; Welsby IJ; Green CL; Dhakal IB; Wellman SS
J Arthroplasty; 2018 Jan; 33(1):55-60. PubMed ID: 28939033
[TBL] [Abstract][Full Text] [Related]
13. Intra-operative blood salvage in total hip and knee arthroplasty.
Dan M; Liu D; Martos SM; Beller E
J Orthop Surg (Hong Kong); 2016 Aug; 24(2):204-8. PubMed ID: 27574264
[TBL] [Abstract][Full Text] [Related]
14. Perioperative blood management programme reduces the use of allogenic blood transfusion in patients undergoing total hip and knee arthroplasty.
Kopanidis P; Hardidge A; McNicol L; Tay S; McCall P; Weinberg L
J Orthop Surg Res; 2016 Feb; 11():28. PubMed ID: 26927608
[TBL] [Abstract][Full Text] [Related]
15. Variation in Use of Blood Transfusion in Primary Total Hip and Knee Arthroplasties.
Menendez ME; Lu N; Huybrechts KF; Ring D; Barnes CL; Ladha K; Bateman BT
J Arthroplasty; 2016 Dec; 31(12):2757-2763.e2. PubMed ID: 27325367
[TBL] [Abstract][Full Text] [Related]
16. Predictors and complications of blood transfusion in total hip and knee arthroplasty.
Frisch NB; Wessell NM; Charters MA; Yu S; Jeffries JJ; Silverton CD
J Arthroplasty; 2014 Sep; 29(9 Suppl):189-92. PubMed ID: 25007727
[TBL] [Abstract][Full Text] [Related]
17. Complete blood count before and after total hip or knee arthroplasty.
Jagow DM; Yacoubian SV; Yacoubian SV
J Orthop Surg (Hong Kong); 2015 Aug; 23(2):209-12. PubMed ID: 26321553
[TBL] [Abstract][Full Text] [Related]
18. Perioperative Telephone Encounters Should Be Included in the Relative Value Scale Update Committee Review of Time Spent on Total Hip and Knee Arthroplasty.
Kheir M; Rondon AJ; Bonaddio V; Tan TL; Wang C; Purtill JJ; Courtney PM
J Arthroplasty; 2019 Aug; 34(8):1563-1569. PubMed ID: 31133427
[TBL] [Abstract][Full Text] [Related]
19. Assessment of the introduction of a blood management program in orthopaedic surgery.
Albinarrate A; López-Picado A; Oiartzabal I; López-Ariznabarreta C; Molano J; Barrachina B
Rev Esp Anestesiol Reanim; 2015 Oct; 62(8):443-9. PubMed ID: 25315985
[TBL] [Abstract][Full Text] [Related]
20. Predictors of allogeneic blood transfusion in total hip and knee arthroplasty in the United States, 2000-2009.
Yoshihara H; Yoneoka D
J Arthroplasty; 2014 Sep; 29(9):1736-40. PubMed ID: 24891002
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
